Evidence map›Paper›PMID 28256614›Full record

ArticleScientific reports2017

MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.

Kun-Chun Chiang, Ta-Sen Yeh, Cheng-Cheng Huang, Yu-Chan Chang, Horng-Heng Juang, Chi-Tung Cheng, Jong-Hwei S Pang, Jun-Te Hsu, Masashi Takano, Tai C Chen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. The role of vitamin D3 in follicle development.Journal of ovarian research · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Kun-Chun ChiangGeneral Surgery Department, Chang Gung Memorial Hospital, Chang Gung University, Keelung, R.O.C, Taiwan.
Ta-Sen YehGeneral Surgery Department and Liver research center, Chang Gung Memorial Hospital, Chang Gung University, Kwei-Shan, Taoyuan, R.O.C, Taiwan.
Cheng-Cheng HuangDepartment of Pathology, Chang Gung Memorial Hospital, 222, Mai-Chin Road, Keelung, R.O.C, Taiwan.
Yu-Chan ChangGenomics Research Center, Academia Sinica, Taipei, R.O.C, Taiwan.
Horng-Heng JuangDepartment of Anatomy, College of Medicine, Chang Gung University, Kwei-Shan, Taoyuan, 333, R.O.C, Taiwan.
Chi-Tung ChengGeneral Surgery Department and Liver research center, Chang Gung Memorial Hospital, Chang Gung University, Kwei-Shan, Taoyuan, R.O.C, Taiwan.
Jong-Hwei S PangGraduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Taoyuan, R.O.C, Taiwan.
Jun-Te HsuGeneral Surgery Department and Liver research center, Chang Gung Memorial Hospital, Chang Gung University, Kwei-Shan, Taoyuan, R.O.C, Taiwan.
Masashi TakanoFaculty of Pharmaceutical Sciences, Teikyo University, Sagamihara, Kanagawa, 252-5195, Japan.
Tai C ChenBoston University School of Medicine, M-1022, 715 Albany Street, Boston, MA 02118, USA.
Atsushi KittakaFaculty of Pharmaceutical Sciences, Teikyo University, Sagamihara, Kanagawa, 252-5195, Japan.
Michael HsiaoGenomics Research Center, Academia Sinica, Taipei, R.O.C, Taiwan.
Chun-Nan YehGeneral Surgery Department and Liver research center, Chang Gung Memorial Hospital, Chang Gung University, Kwei-Shan, Taoyuan, R.O.C, Taiwan.
Chang Gung University · TWGenomics Research Center, Academia Sinica · TWTeikyo University · JPBoston University · USChang Gung Memorial Hospital · TWKeelung Chang Gung Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholangiocarcinoma (CCA) is a devastating disease due to no effective treatments available. Since the non-mineral functions of vitamin D emerges, 1α,25(OH)

Indexed as

Xenograft Model Antitumor AssaysAgedAnimalsBile Duct NeoplasmsCell Line, TumorCell ProliferationCholangiocarcinomaCholecalciferolFemaleGene Knockdown TechniquesHumansKaplan-Meier EstimateMaleMice, Inbred NODMice, KnockoutMice, SCID19-nor-2-(3-hydroxypropyl)-1,25-dihydroxyvitamin D3CholecalciferolReceptors, Calcitriol

Identifiers

PMID28256614
PMCPMC5335655
OpenAlexW2592380391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.